ARCHIVES

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Program Bill Renews Congressional Commitment To Principles, Rep. Carter Says

May 5, 1978

In Brief: O’Conor Names NCI Liaison To IARC, Saunders Acting IA Director Susan Sieber DCCP Deputy

May 27, 1983

How the Institute Fared In House Markup: Chart

July 18, 1997

US Appeals Court Dismisses Fisher’s Privacy Act Suit Supporting Femara

January 10, 1997

In Brief: Curt Appointment Now Official; Bipartisan Effort Seeks $150 Million FDA Budget Increase

April 21, 1989

Grant Supplements, and Challenge Grants

February 20, 2009